General discussion, page-18805

First 18805 Last

Share
Profile

Follow
rusty02

3,848 Posts.

1920

12/12/23

16:28

Post #: 71409086
Share

Originally posted by Rickali01: ↑

I sent an email to Joel asking about the MC issue - earlier today.

He has already replied saying they are aware of this issue and are working with NASDAQ to get it fixed. He noted that whilst you would think this would be a simple exercise to correct, it has not been and they are hoping for a resolution asap.

Joel did not say this next bit but it is pretty obvious what the error is. Our MC should be calculated as follows:

- Number of shares which left Aus (~1.55B) divided by 100 equals number of shares on the NASDAQ. Multiply by US$5 = USD77.5m MC.

Instead, the NASDAQ are still using 25 as the denominator - which was used to calculate the value of the ADR's or whatever they were called.

- So they are taking 1.55B divided by 25 and then multiplied by US$5 per share = USD310m. I have rounded my numbers and stuff so it doesn't tie perfectly but it is close enough to make it obvious why the NASDAQ is wrong.

My view is that this could be acting as a deterrent to potential shareholders but per@rusty02 comment above, I agree that any impact is likely to be short term. - they just need to fix it.

Good luck to all.

Expand

Correct @Rickall01

It seems to be the US Valuers not fully understanding the AU IHL Redomicile/consolidation configuration to the US IXHL. This won't be an issue in the not to distant future

Hi @Conner109
You'll find the CEO prompt with his responses and always replies If you have further issues in relation to the US valuation thrown around ATM please email the company
As @Driver1 said. Teething problems.

IHL Price at posting: 4.1¢ Sentiment: Buy Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

There are more pages in this discussion • 1,634 more messages in this thread...

First 18805 Last

Add IHL (ASX) to my watchlist

General discussion, page-18805

Top Stories

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Featured News